The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

New breakthroughs in gene editing mean that cures for genetic diseases such as cystic fibrosis could be developed in the near future.

What's better than one dual meet? Two, of course. General McLane wrestling hosted the Corry boys and girls for a doubleheader Thursday on "Takedown Cystic Fibrosis" night.

A new charity football team in Peterborough has been set up to honour the memory of Jordan Smith and raise awareness of ...

Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

Miss America pageant will take place in Orlando on January 5. This year's contestants include a national figure skater and a ...

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

LCI proves valuable in monitoring ETI therapy effectiveness for cystic fibrosis patients with minimal FEV1 changes, detecting ...

SION-2851 is under development for the treatment of cystic fibrosis. It is a small molecule administered orally. It is a first generation corrector. The drug candidate targets cystic fibrosis ...

Sophie Pierce is determined to make the most of her life - however long she may have.

The interview delves into how Craig's upbringing in Upstate New York shaped his approach to business and life. Reflecting on his values, Craig credits his early experiences with instilling a deep ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...